Venture capital firms invested more than $2.9 billion in medical device companies in 2018 — a slight increase from the $2.8 billion raised in 2017, according to the MoneyTree report from PricewaterhouseCoopers (PwC) and CB Insights.

Both the first and second quarters of 2018 saw an increase in investments, totaling nearly $778 million and $786 million respectively. The third and fourth quarters were slightly lower, with medtech companies raising $738 million in Q3 and nearly $641 million in Q4.

There were 218 deals in 2018, a slight decrease from the 229 deals involving medical device companies in 2017. There was 55 deals in Q1, 68 in Q2, 48 in Q3 and 47 in Q4.

The companies that are raising VC cash are doing everything from cardiac arrhythmia detection to proton therapy for cancer patients.

Read on to discover the top medtech venture capital raises of 2018.

Next >>